Piotr Tomasz Lassota

age ~68

from Wake Forest, NC

Get Report
Also known as:
  • Piotr T Lassota
  • Piotr Iwona Lassota
  • Peter T Lassota
  • Tiotr Lassota
Phone and address:
7816 Hasentree Lake Dr, Wake Forest, NC 27587
9194884934
Related to:
Connected to:

Piotr Lassota Phones & Addresses

  • 7816 Hasentree Lake Dr, Wake Forest, NC 27587 • 9194884934
  • Raleigh, NC
  • Franklin, MA
  • 5 Summit Way, Hopkinton, MA 01748 • 5086251622 • 5084102401
  • 99 Hillside Ave, Succasunna, NJ 07876 • 9732527464
  • Westborough, MA
  • Nanuet, NY
  • New York, NY

Work

  • Company:
    Polpharma
    Sep 2010
  • Address:
    Warszaw, Poland
  • Position:
    Board member. cso and head of r&d, polpharma biologics

Education

  • Degree:
    Ph.D.
  • School / High School:
    Institute of Biochem. & Biophys., Polish Academy Of Sciences
    1981 to 1986
  • Specialities:
    Biochemistry

Skills

Drug Discovery and Development • Articulating and Executing R&D Strategies • Building R&D Teams • Providing Unequivocal Leadership and Dir... • Working With Diverse Teams With Various ... • Designing R&D Laboratories and Pilot Man... • Leading R&D Efforts In Pharma and Biotec... • Attracting External Fuding • Small Molecules and Biopharmaceuticals • Oncology • Pharmacology • Biochemistry and Molecular Biology • Technology Transfer • Iacuc Chair • Designing Animal Facilities • Drug Discovery • R&D • Biotechnology • Drug Development • Gcp • Lifesciences • Pharmaceutical Industry • Laboratory • Strategy • Biopharmaceuticals • Protein Chemistry • Biomarkers • Chemistry • Gmp • Translational Medicine • Clinical Development • Glp • Validation • Clinical Trials • Regulatory Affairs • Vaccines • Regulatory Submissions • Biochemistry • Sop • V&V • Fda • Formulation • Chromatography • Cro • Life Sciences

Languages

English • Polish • German • Russian

Interests

Personalized Medicines • Rational Drug Combinations • New Technologies • Rollerblading • Biomarkers • Travel

Industries

Biotechnology

Resumes

Piotr Lassota Photo 1

Accomplished Executive Pharma And Biotech Leader

view source
Location:
Wake Forest, NC
Industry:
Biotechnology
Work:
Polpharma - Warszaw, Poland since Sep 2010
Board Member. CSO and Head of R&D, Polpharma Biologics
CaliperLS Jul 2006 - 2010
Divisional VP
Novartis Jan 2002 - Sep 2006
Executive Director
Education:
Institute of Biochem. & Biophys., Polish Academy Of Sciences 1981 - 1986
Ph.D., Biochemistry
Skills:
Drug Discovery and Development
Articulating and Executing R&D Strategies
Building R&D Teams
Providing Unequivocal Leadership and Directions To the Team
Working With Diverse Teams With Various Cultural Backgrounds
Designing R&D Laboratories and Pilot Manufacturing
Leading R&D Efforts In Pharma and Biotech Settings
Attracting External Fuding
Small Molecules and Biopharmaceuticals
Oncology
Pharmacology
Biochemistry and Molecular Biology
Technology Transfer
Iacuc Chair
Designing Animal Facilities
Drug Discovery
R&D
Biotechnology
Drug Development
Gcp
Lifesciences
Pharmaceutical Industry
Laboratory
Strategy
Biopharmaceuticals
Protein Chemistry
Biomarkers
Chemistry
Gmp
Translational Medicine
Clinical Development
Glp
Validation
Clinical Trials
Regulatory Affairs
Vaccines
Regulatory Submissions
Biochemistry
Sop
V&V
Fda
Formulation
Chromatography
Cro
Life Sciences
Interests:
Personalized Medicines
Rational Drug Combinations
New Technologies
Rollerblading
Biomarkers
Travel
Languages:
English
Polish
German
Russian
Name / Title
Company / Classification
Phones & Addresses
Piotr Lassota
Owner
Lassota, Piotr
School/Educational Services
68 Elm St, Hopkinton, MA 01748

Us Patents

  • Rapid Method For Screening Compounds For In Vivo Activity

    view source
  • US Patent:
    20070105147, May 10, 2007
  • Filed:
    Dec 21, 2006
  • Appl. No.:
    11/643248
  • Inventors:
    Piotr Lassota - Succasunna NJ, US
  • International Classification:
    C12Q 1/68
    C12Q 1/66
  • US Classification:
    435006000, 435008000
  • Abstract:
    The present invention provides a rapid method for screening potentially pharmaceutically useful compounds for activity in vivo. The method has the steps of growing a target cell into which a reporter gene was introduced in a biocompatible, semipermeable encapsulation device; implanting the semi-permeable encapsulation device into a subject; administering a potentially pharmaceutically active compound to said subject; removing said encapsulation device from said subject after in vivo exposure to the potentially pharmaceutically active compound and evaluating said target cell for reaction to said potentially pharmaceutically active compound by measuring the expression of said reporter gene.

  • Rapid Method For Screening Compounds For In Vivo Activity

    view source
  • US Patent:
    20040067540, Apr 8, 2004
  • Filed:
    Jul 7, 2003
  • Appl. No.:
    10/250739
  • Inventors:
    Piotr Lassota - Succasunna NJ, US
  • International Classification:
    G01N033/574
  • US Classification:
    435/007230
  • Abstract:
    The present invention provides a rapid method for screening potentially pharmaceutically useful compounds for activity in vivo. The method has the steps of growing a target cell into which a reporter gene was introduced in a biocompatible, semipermeable encapsulation device; implanting the semi-permeable encapsulation device into a subject; administering a potentially pharmaceutically active compound to said subject; removing said encapsulation device from said subject after in vivo exposure to the potentially pharmaceutically active compound and evaluating said target cell for reaction to said potentially paharmaceutically active compound by measuring the expression of said reporter gene.
Get Report for Piotr Tomasz Lassota from Wake Forest, NC, age ~68
Control profile